Calcineurin Inhibitor Nephrotoxicity
Data up to Jan 2025
Total Citations Per Year
Abstract
References (384)
Case 39-2000
2000 • 3,891 citations
An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels.
1990 • 3,809 citations
Transforming Growth Factor β in Tissue Fibrosis
1994 • 3,055 citations
The Banff 97 working classification of renal allograft pathology
1999 • 3,028 citations
TRANSCRIPTION FACTORS OF THE NFAT FAMILY:Regulation and Function
1997 • 2,571 citations
A "Silent" Polymorphism in the MDR 1 Gene Changes Substrate Specificity
2006 • 2,347 citations
Sequence diversity in CYP3A promoters and characterization of the genetic basis of polymorphic CYP3A5 expression
2001 • 2,120 citations
Chronic Renal Failure after Transplantation of a Nonrenal Organ
2003 • 2,101 citations
The Natural History of Chronic Allograft Nephropathy
2003 • 1,899 citations
Banff 07 Classification of Renal Allograft Pathology: Updates and Future Directions
2008 • 1,828 citations
Reduced Exposure to Calcineurin Inhibitors in Renal Transplantation
2007 • 1,692 citations
Identification of calcineurin as a key signalling enzyme in T-lymphocyte activation
1992 • 1,634 citations
NFAT proteins: key regulators of T-cell development and function
2005 • 1,434 citations
International standardization of criteria for the histologic diagnosis of renal allograft rejection: The Banff working classification of kidney transplant pathology
1993 • 1,431 citations
Cyclophilin and peptidyl-prolyl cis-trans isomerase are probably identical proteins
1989 • 1,414 citations
A receptor for the immuno-suppressant FK506 is a cis–trans peptidyl-prolyl isomerase
1989 • 1,376 citations
Cyclosporine-Associated Chronic Nephropathy
1984 • 1,174 citations
Absence of the mdr1a P-Glycoprotein in mice affects tissue distribution and pharmacokinetics of dexamethasone, digoxin, and cyclosporin A.
1995 • 1,109 citations
Peptidyl-prolyl cis-trans isomerase is the cyclosporin A-binding protein cyclophilin
1989 • 1,087 citations
CYCLOSPORIN A INITIALLY AS THE ONLY IMMUNOSUPPRESSANT IN 34 RECIPIENTS OF CADAVERIC ORGANS: 32 KIDNEYS, 2 PANCREASES, AND 2 LIVERS
1979 • 1,078 citations
Banff ’05 Meeting Report: Differential Diagnosis of Chronic Allograft Injury and Elimination of Chronic Allograft Nephropathy (’CAN’)
2007 • 1,073 citations
Nuclear association of a T-cell transcription factor blocked by FK-506 and cyclosporin A
1991 • 1,054 citations
Antibody-Mediated Rejection Criteria - an Addition to the Banff ’97 Classification of Renal Allograft Rejection
2003 • 1,049 citations
FK 506 FOR LIVER, KIDNEY, AND PANCREAS TRANSPLANTATION
1989 • 1,043 citations
Epithelial to Mesenchymal Transition in Renal Fibrogenesis
2004 • 1,036 citations
CYCLOSPORIN A IN PATIENTS RECEIVING RENAL ALLOGRAFTS FROM CADAVER DONORS
1978 • 1,010 citations
A cytosolic binding protein for the immunosuppressant FK506 has peptidyl-prolyl isomerase activity but is distinct from cyclophilin
1989 • 1,010 citations
Efficacy of sirolimus compared with azathioprine for reduction of acute renal allograft rejection: a randomised multicentre study
2000 • 922 citations
FK-506- and CsA-sensitive activation of the interleukin-2 promoter by calcineurin
1992 • 865 citations
Costimulation Blockade with Belatacept in Renal Transplantation
2005 • 833 citations
Clinical Pharmacokinetics and Pharmacodynamics of Tacrolimus in Solid Organ Transplantation
2004 • 828 citations
The T-cell transcription factor NFATp is a substrate for calcineurin and interacts with Fos and Jun
1993 • 769 citations
Cyclosporin A Specifically Inhibits Function of Nuclear Proteins Involved in T Cell Activation
1989 • 679 citations
Human P-glycoprotein transports cyclosporin A and FK506.
1993 • 676 citations
Genetic polymorphisms of the CYP3A4, CYP3A5, and MDR-1 genes and pharmacokinetics of the calcineurin inhibitors cyclosporine and tacrolimus
2003 • 646 citations
Morphology, physiology, and molecular biology of renin secretion
1990 • 610 citations
GYNAECOLOGISTS' ATTITUDES TO ABORTION
1989 • 605 citations
Results of an International, Randomized Trial Comparing Glucose Metabolism Disorders and Outcome with Cyclosporine Versus Tacrolimus
2007 • 589 citations
Tacrolimus versus ciclosporin as primary immunosuppression for kidney transplant recipients: meta-analysis and meta-regression of randomised trial data
2005 • 563 citations
Clinical Pharmacokinetics of Cyclosporin
1986 • 488 citations
Calcineurin Inhibitor Nephrotoxicity: Longitudinal Assessment by Protocol Histology
2004 • 486 citations
Long-Term Outcome of Renal Transplantation from Older Donors
2006 • 479 citations
Renin-Angiotensin-Aldosterone System and Progression of Renal Disease
2006 • 451 citations
Chronic cyclosporine nephropathy: The Achilles' heel of immunosuppressive therapy
1996 • 443 citations
Rethinking Chronic Allograft Nephropathy
1999 • 443 citations
The effect of CYP3A5 and MDR1 (ABCB1) polymorphisms on cyclosporine and tacrolimus dose requirements and trough blood levels in stable renal transplant patients
2004 • 434 citations
Effect of cyclosporine administration on renal hemodynamics in conscious rats
1985 • 416 citations
Signals Transduced by Ca2+/Calcineurin and NFATc3/c4 Pattern the Developing Vasculature
2001 • 412 citations
Risk Factors for Cyclosporine-Induced Nephropathy in Patients with Autoimmune Diseases
1992 • 409 citations
A Meta-Analysis of Immunosuppression Withdrawal Trials in Renal Transplantation
2000 • 391 citations
HISTOPATHOLOGIC FINDINGS FROM 2-YEAR PROTOCOL BIOPSIES FROM A U.S. MULTICENTER KIDNEY TRANSPLANT TRIAL COMPARING TACROLIMUS VERSUS CYCLOSPORINE
1998 • 371 citations
Role of endothelin in cyclosporine-induced glomerular dysfunction
1990 • 368 citations
Renal Histopathologic Alterations in Patients Treated with Cyclosporine for Uveitis
1986 • 350 citations
Immunosuppressive drugs prevent a rapid dephosphorylation of transcription factor NFAT1 in stimulated immune cells.
1995 • 347 citations
Cyclosporin Clinical Pharmacokinetics
1993 • 338 citations
South Africa
1985 • 333 citations
Renal effects of selective cyclooxygenase-2 inhibition in normotensive salt-depleted subjects
1999 • 323 citations
Tacrolimus with Mycophenolate Mofetil (MMF) or Sirolimus vs. Cyclosporine with MMF in Cardiac Transplant Patients: 1-Year Report
2006 • 321 citations
Tacrolimus pharmacogenetics: polymorphisms associated with expression of cytochrome p4503A5 and p-glycoprotein correlate with dose requirement
2002 • 318 citations
THE TEMPORAL PROFILE OF CALCINEURIN INHIBITION BY CYCLOSPORINE IN VIVO1
1999 • 317 citations
Calcineurin inhibitor‐sparing regimens in solid organ transplantation: focus on improving renal function and nephrotoxicity
2007 • 310 citations
Up-regulation of Multidrug Resistance P-glycoprotein via Nuclear Factor-κB Activation Protects Kidney Proximal Tubule Cells from Cadmium- and Reactive Oxygen Species-induced Apoptosis
2000 • 305 citations
Mechanisms of Clinically Relevant Drug Interactions Associated with Tacrolimus
2002 • 303 citations
CYCLOSPORINE-INDUCED ACUTE RENAL DYSFUNCTION IN THE RAT EVIDENCE OF ARTERIOLAR VASOCONSTRICTION WITH PRESERVATION OF TUBULAR FUNCTION
1987 • 303 citations
RELATIONSHIP OF FK506 WHOLE BLOOD CONCENTRATIONS AND EFFICACY AND TOXICITY AFTER LIVER AND KIDNEY TRANSPLANTATION
1996 • 300 citations
Renal injury due to renin–angiotensin–aldosterone system activation of the transforming growth factor-β pathway
2006 • 285 citations
Nephrotoxicity of immunosuppressive drugs: new insight and preventive strategies
2001 • 284 citations
Association of the Multidrug Resistance-1 Gene Single-Nucleotide Polymorphisms with the Tacrolimus Dose Requirements in Renal Transplant Recipients
2003 • 281 citations
International variation in the interpretation of renal transplant biopsies: Report of the CERTPAP Project11A complete listing of the participants who all contributed equally to the work of the CERTPAP Project includes Peter N. Furness (Leicester, UK); Nicholas Taub (Leicester, United Kingdom); Karel J.M. Assmann (Nijmegen, The Netherlands); Giovanni Banfi (Milan, Italy); John N. Botelis (Athens, Greece); Marta Carrera (Barcelona, Spain); Jean-Pierre Cosyns (Brussels, Belgium); Anthony M. Dorman…
2001 • 280 citations
Kidney and Pancreas Transplantation in the United States, 1996–2005
2007 • 271 citations
The side-effects of ciclosporine-A and tacrolimus.
1998 • 270 citations
Cyclosporine Sparing with Mycophenolate Mofetil, Daclizumab and Corticosteroids in Renal Allograft Recipients: The CAESAR Study
2007 • 264 citations
Acute renal failure with selective medullary injury in the rat.
1988 • 262 citations
EFFECT OFCYP3A5POLYMORPHISM ON TACROLIMUS METABOLIC CLEARANCE IN VITRO
2006 • 260 citations
Tacrolimus versus microemulsified ciclosporin in liver transplantation: the TMC randomised controlled trial
2002 • 257 citations
NEPHROTOXICITY OF CYCLOSPORIN A IN LIVER AND KIDNEY TRANSPLANT PATIENTS
1981 • 252 citations
Pathogenesis of cyclosporine nephropathy
1995 • 250 citations
Influence of CYP3A5 and MDR1 (ABCB1) Polymorphisms on the Pharmacokinetics of Tacrolimus in Renal Transplant Recipients
2004 • 248 citations
Is cyclophilin involved in the immunosuppressive and nephrotoxic mechanism of action of cyclosporin A?
1991 • 248 citations
Cyclosporine-Induced Hyperuricemia and Gout
1989 • 247 citations
Silent SNPs: Impact on Gene Function and Phenotype
2007 • 241 citations
Kidney Transplantation Under FK 506
1990 • 236 citations
Juxtaglomerular cell complex in the regulation of renal salt excretion
1998 • 230 citations
Clinically Significant Drug Interactions with Cyclosporin
1996 • 229 citations
RAPAMYCIN: CLINICAL RESULTS AND FUTURE OPPORTUNITIES1
2001 • 224 citations
Pharmacokinetic Interactions Augment Toxicities of Sirolimus/Cyclosporine Combinations
2001 • 222 citations
AN OPEN-LABEL, CONCENTRATION-RANGING TRIAL OF FK506 IN PRIMARY KIDNEY TRANSPLANTATION
1996 • 218 citations
Calcium channel blockers protect transplant patients from cyclosporine-induced daily renal hypoperfusion
1993 • 217 citations
Calcineurin
1999 • 217 citations
Three‐Year Efficacy and Safety Results from a Study of Everolimus Versus Mycophenolate Mofetil in de novo Renal Transplant Patients
2005 • 217 citations
The Histopathological Changes Associated with Allograft Rejection and Drug Toxicity in Renal Transplant Recipients Maintained on FK506
1993 • 216 citations
ABCB1 Genotype of the Donor but Not of the Recipient Is a Major Risk Factor for Cyclosporine-Related Nephrotoxicity after Renal Transplantation
2005 • 213 citations
Glomerular hemodynamics and hormonal participation on cyclosporine nephrotoxicity
1987 • 210 citations
Angiotensin II blockade decreases TGF-β1 and matrix proteins in cyclosporine nephropathy
1997 • 207 citations
International Variation in Histologic Grading Is Large, and Persistent Feedback Does Not Improve Reproducibility
2003 • 206 citations
CYP3A5 and CYP3A4 but not MDR1 Single-nucleotide Polymorphisms Determine Long-term Tacrolimus Disposition and Drug-related Nephrotoxicity in Renal Recipients
2007 • 205 citations
Tacrolimus Pharmacogenetics: The CYP3A5*1 Allele Predicts Low Dose-Normalized Tacrolimus Blood Concentrations in Whites and South Asians
2005 • 204 citations
Dephosphorylation of Endothelial Nitric-oxide Synthase by Vascular Endothelial Growth Factor
2002 • 190 citations
Randomized trial of tacrolimus in combination with sirolimus or mycophenolate mofetil in kidney transplantation: results at 6 months1
2003 • 189 citations
CYP3A5 and MDR1 genetic polymorphisms and cyclosporine pharmacokinetics after renal transplantation
2004 • 187 citations
Computerized Image Analysis of Sirius Red–Stained Renal Allograft Biopsies as a Surrogate Marker to Predict Long-Term Allograft Function
2003 • 187 citations
Renal cell apoptosis induced by nephrotoxic drugs: cellular and molecular mechanisms and potential approaches to modulation
2007 • 183 citations
Immunophilins in the Nervous System
1998 • 181 citations
Renal Transplant-Associated Hyperuricemia and Gout
2000 • 181 citations
Intravenous cyclosporine activates afferent and efferent renal nerves and causes sodium retention in innervated kidneys in rats.
1985 • 179 citations
Cyclosporin A increases hypoxia and free radical production in rat kidneys: prevention by dietary glycine
1998 • 178 citations
Endothelin mediates the renal vasoconstriction induced by cyclosporine in the rat.
1990 • 176 citations
Cellular proliferation and macrophage influx precede interstitial fibrosis in cyclosporine nephrotoxicity
1995 • 174 citations
Population pharmacokinetics of cyclosporine in kidney and heart transplant recipients and the influence of ethnicity and genetic polymorphisms in the and genes
2004 • 172 citations
Accelerated apoptosis characterizes cyclosporine-associated interstitial fibrosis
1998 • 170 citations
Lipid peroxidation accompanies cyclosporine nephrotoxicity: Effects of vitamin E
1995 • 166 citations
PEAK-FLOW METER VERSUS PEAK-FLOW GAUGE
1974 • 165 citations
AUC-guided dosing of tacrolimus prevents progressive systemic overexposure in renal transplant recipients
2005 • 165 citations
Ketoconazole to Reduce the Need for Cyclosporine after Cardiac Transplantation
1995 • 164 citations
Apoptosis and necrosis: Mechanisms of cell death induced by cyclosporine A in a renal proximal tubular cell line
1998 • 161 citations
CHRONIC INJURY OF HUMAN RENAL MICROVESSELS WITH LOW-DOSE CYCLOSPORINE THERAPY
1988 • 160 citations
The impact of aging on kidney repair
2008 • 158 citations
Cyclosporine A-Induced Renal Fibrosis
2005 • 153 citations
Losartan decreases plasma levels of TGF-β1 in transplant patients with chronic allograft nephropathy
1999 • 152 citations
Ciclosporin in psoriasis clinical practice: an international consensus statement
2004 • 152 citations
N-acetylcysteine attenuates cyclosporin-induced nephrotoxicity in rats
1999 • 149 citations
Expression of TGF-β and fibrogenic genes in transplant recipients with tacrolimus and cyclosporine nephrotoxicity
2002 • 149 citations
Prevention of Acute Graft Rejection by the Prostaglandin E1Analogue Misoprostol in Renal-Transplant Recipients Treated with Cyclosporine and Prednisone
1990 • 147 citations
INTERSTITIAL FIBROSIS IN RENAL ALLOGRAFTS AFTER 12 TO 46 MONTHS OF CYCLOSPORIN TREATMENT: BENEFICIAL EFFECT OF LOW DOSES IN EARLY POST-TRANSPLANTATION PERIOD
1984 • 147 citations
Different effects of tacrolimus and cyclosporine on renal hemodynamics and blood pressure in healthy subjects
2002 • 147 citations
Evaluation of renal function in liver transplant recipients receiving daclizumab (Zenapax), mycophenolate mofetil, and a delayed, low-dose tacrolimus regimen vs. a standard-dose tacrolimus and mycophenolate mofetil regimen: A multicenter randomized clinical trial
2005 • 145 citations
Cyclosporine Microemulsion (Neoral®) Absorption Profiling and Sparse-sample Predictors During the First 3 Months after Renal Transplantation
2002 • 144 citations
Therapeutic benefit of spironolactone in experimental chronic cyclosporine A nephrotoxicity
2003 • 144 citations
Global glomerular sclerosis and glomerular arteriolar hyalinosis in insulin dependent diabetes
1991 • 144 citations
Molecular Determinants of Magnesium Homeostasis
2008 • 141 citations
IMMUNOLOGICAL AND PHARMACOLOGICAL MONITORING IN THE CLINICAL USE OF CYCLOSPORIN A
1981 • 141 citations
Increased Expression of Senescence-Associated Cell Cycle Inhibitor p16 in Deteriorating Renal Transplants and Diseased Native Kidney
2005 • 138 citations
Dissociation of glomerular filtration rate from tubulointerstitial fibrosis in experimental chronic cyclosporine nephropathy
1993 • 136 citations
ONE-YEAR FOLLOW-UP OF AN OPEN-LABEL TRIAL OF FK506 FOR PRIMARY KIDNEY TRANSPLANTATION1
1996 • 135 citations
Early Epithelial Phenotypic Changes Predict Graft Fibrosis
2008 • 135 citations
Bartter’s and Gitelman’s Syndromes: From Gene to Clinic
2004 • 134 citations
SYNERGISTIC EFFECTS OF CYCLOSPORINE AND RAPAMYCIN IN A CHRONIC NEPHROTOXICITY MODEL1
1996 • 133 citations
Predictors and Evolution of Renal Function during 9 Years Following Heart Transplantation
2000 • 131 citations
Minimizing Immunosuppression, an Alternative Approach to Reducing Side Effects
2008 • 130 citations
New insights into the pathophysiology of cyclosporine nephrotoxicity: a role of aldosterone
2007 • 130 citations
Cyclosporine A induces senescence in renal tubular epithelial cells
2007 • 128 citations
Oxidative stress as a common pathway to chronic tubulointerstitial injury in kidney allografts
2007 • 128 citations
Therapeutic Role of TGF-β–Neutralizing Antibody in Mouse Cyclosporin A Nephropathy
2003 • 127 citations
SUSTAINED IMPROVEMENT OF RENAL GRAFT FUNCTION FOR TWO YEARS IN HYPERTENSIVE RENAL TRANSPLANT RECIPIENTS TREATED WITH NIFEDIPINE AS COMPARED TO LISINOPRIL1
2001 • 125 citations
Expression of apoptosis regulatory genes in chronic cyclosporine nephrotoxicity favors apoptosis
1999 • 125 citations
Reliability of chronic allograft nephropathy diagnosis in sequential protocol biopsies
2002 • 122 citations
Early and Late Forms of Cyclosporine Nephrotoxicity: Studies in Cardiac Transplant Recipients
1987 • 121 citations
Activation of NFATc3 Down-regulates the β1 Subunit of Large Conductance, Calcium-activated K+ Channels in Arterial Smooth Muscle and Contributes to Hypertension
2006 • 121 citations
Effect of anti-transforming growth factor-βbgr; antibodies in cyclosporine-induced renal dysfunction
2001 • 121 citations
Pravastatin treatment attenuates interstitial inflammation and fibrosis in a rat model of chronic cyclosporine-induced nephropathy
2004 • 120 citations
Morphological patterns in cyclosporine-treated renal transplant recipients.
1985 • 119 citations
Acute renal failure associated with immunoglobulin therapy
1995 • 119 citations
HIV-associated nephropathy in African Americans11The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the U.S. Government. The publisher or recipient acknowledges right of the U.S. Government to retain a nonexclusive, royalty-free license in and to any copyright covering the article.
2003 • 117 citations
Generation and Evolution of Atubular Glomeruli in the Progression of Renal Disorders
2008 • 117 citations
REPRODUCIBILITY OF THE BANFF CLASSIFICATION OF RENAL ALLOGRAFT PATHOLOGY
1995 • 117 citations
Cytochrome P450 3A4 and P-glycoprotein Activity and Assimilation of Tacrolimus in Transplant Patients with Persistent Diarrhea
2005 • 117 citations
Role of P-glycoprotein in cyclosporine cytotoxicity in the cyclosporine–sirolimus interaction
2006 • 114 citations
Vascular mechanisms of cyclosporin-induced hypertension in the rat.
1994 • 113 citations
The Clinical Benefits of Cyclosporine C2-Level Monitoring: A Systematic Review
2007 • 112 citations
Long-Term Graft Survival with Neoral and Tacrolimus
2003 • 112 citations
Renal insufficiency after heart transplantation: a case-control study
1998 • 111 citations
Cyclosporine produces endothelial dysfunction by increased production of superoxide.
1994 • 111 citations
Time-Related Clinical Determinants of Long-Term Tacrolimus Pharmacokinetics in Combination Therapy with Mycophenolic Acid and Corticosteroids
2004 • 111 citations
Converting-enzyme inhibitor versus calcium antagonist in cyclosporine-treated renal transplants
1993 • 110 citations
NFATc3 Regulates Kv2.1 Expression in Arterial Smooth Muscle
2004 • 110 citations
Cyclosporine A induced arteriolopathy in a rat model of chronic cyclosporine nephropathy
1995 • 109 citations
Expression of MDR1 (Multidrug Resistance) Gene and Its Protein in Normal Human Kidney
1997 • 108 citations
Effects of Losartan and Amlodipine on Intrarenal Hemodynamics and TGF-β1 Plasma Levels in a Crossover Trial in Renal Transplant Recipients
2001 • 107 citations
The Aggravating Mechanisms of Aldosterone on Kidney Fibrosis
2008 • 107 citations
Cyclosporine A enhances renin secretion and production in isolated juxtaglomerular cells
1988 • 105 citations
Impact of MDR1 and CYP3A5 on the oral clearance of tacrolimus and tacrolimus-related renal dysfunction in adult living-donor liver transplant patients
2008 • 105 citations
Expression and Function of the Nuclear Factor of Activated T Cells in Colon Carcinoma Cells
2005 • 104 citations
Further metabolism of FK506 (tacrolimus). Identification and biological activities of the metabolites oxidized at multiple sites of FK506.
1995 • 103 citations
Tacrolimus versus ciclosporin immunosuppression: long-term outcome in renal transplantation
2003 • 103 citations
A CONTROLLED TRIAL OF CYCLOSPORINE IN RENAL TRANSPLANTATION WITH CONVERSION TO AZATHIOPRINE AND PREDNISOLONE AFTER THREE MONTHS
1983 • 103 citations
Time Course of the Decline in Renal Function in Cyclosporine-Treated Heart Transplant Recipients
1994 • 102 citations
Risk Factors for Early Epithelial to Mesenchymal Transition in Renal Grafts
2006 • 102 citations
A Randomized Long-Term Trial of Tacrolimus/Sirolimus versus Tacrolimums/Mycophenolate versus Cyclosporine/Sirolimus in Renal Transplantation: Three-Year Analysis
2006 • 101 citations
Stimulation of transforming growth factor‐β1 transcription by cyclosporine
1995 • 101 citations
Nephron segment-specific inhibition of Na+/K+-ATPase activity by cyclosporin A
1993 • 100 citations
DE NOVO COLLAPSING GLOMERULOPATHY IN RENAL ALLOGRAFTS1
1998 • 99 citations
Transcriptional analysis of the molecular basis of human kidney aging using cDNA microarray profiling
2005 • 95 citations
Cytochrome P450 3A Polymorphisms and Immunosuppressive Drugs: An Update
2007 • 93 citations
STUDIES ON THE IMMUNOSUPPRESSIVE PROPERTIES OF CYCLOSPORIN A IN RATS RECEIVING RENAL ALLOGRAFTS
1980 • 93 citations
The Pharmacogenetics of Calcineurin Inhibitors: One Step Closer Toward Individualized Immunosuppression?
2005 • 93 citations
Urinary endothelin and renal vasoconstriction with cyclosporine or FK506 after liver transplantation
1995 • 92 citations
Gemcitabine-associated hemolytic-uremic syndrome
2002 • 92 citations
Expression of multidrug resistance P-glycoprotein in kidney allografts from cyclosporine A-treated patients
2001 • 92 citations
Risk factors for renal glomerular and vascular changes in an autopsy-based population survey: The Hisayama Study
2003 • 89 citations
Calcium Channel Blockade and Preservation of Renal Graft Function in Cyclosporine-Treated Recipients: A Prospective Randomized Placebo-Controlled 2-Year Study
2004 • 89 citations
A Comparison of Tacrolimus and Cyclosporine in Liver Transplantation: Effects on Renal Function and Cardiovascular Risk Status
2005 • 89 citations
CYCLOSPORINE PLASMA LEVELS IN RENAL TRANSPLANT PATIENTS
1985 • 88 citations
Low Intraindividual Variability of Cyclosporin A Exposure Reduces Chronic Rejection Incidence and Health Care Costs
2000 • 88 citations
COMPUTERIZED HISTOMORPHOMETRIC ASSESSMENT OF PROTOCOL RENAL TRANSPLANT BIOPSY SPECIMENS FOR SURROGATE MARKERS OF CHRONIC REJECTION
1999 • 87 citations
Efficacy of ISA247 in plaque psoriasis: a randomised, multicentre, double-blind, placebo-controlled phase III study
2008 • 87 citations
No Difference in Degree of Interstitial Sirius Red–Stained Area in Serial Biopsies from Area under Concentration-over-Time Curves–Guided Cyclosporine versus Tacrolimus-Treated Renal Transplant Recipients at One Year
2005 • 86 citations
Potentiation by Nitric Oxide of Cyclosporin A and FK506-Induced Apoptosis in Renal Proximal Tubule Cells
2000 • 86 citations
Cyclosporine A-induced hypertension involves synapsin in renal sensory nerve endings
2000 • 85 citations
Association between ABCB1 (multidrug resistance transporter) genotype and post-liver transplantation renal dysfunction in patients receiving calcineurin inhibitors
2003 • 85 citations
Hypertensive nephrosclerosis: pathogenesis and prevalence
1999 • 85 citations
Effect of nitrendipine on renal function in renal-transplant patients treated with cyclosporin: a randomised trial
1999 • 85 citations
Cyclosporin A treatment induces overexpression of P-glycoprotein in the kidney and other tissues
1996 • 84 citations
Tacrolimus Exposure and Evolution of Renal Allograft Histology in the First Year After Transplantation
2007 • 84 citations
Morphology of cyclosporine nephrotoxicity in the rat.
1986 • 79 citations
Expression of Apoptosis-related Genes in Chronic Cyclosporine Nephrotoxicity in Mice
2002 • 79 citations
Cyclosporin A Inhibits Flow-mediated Activation of Endothelial Nitric-oxide Synthase by Altering Cholesterol Content in Caveolae
2004 • 79 citations
Contribution of tubular injury to loss of remnant kidney function
1998 • 78 citations
ORAL CYCLOSPORINE BUT NOT TACROLIMUS REDUCES RENAL TRANSPLANT BLOOD FLOW
2004 • 77 citations
Blood Vessels and the Aging Kidney
2005 • 77 citations
The Role of Therapeutic Drug Monitoring in Individualizing Immunosuppressive Drug Therapy: Recent Developments
2006 • 76 citations
CYCLOSPORINE-INDUCED INTERSTITIAL FIBROSIS AND ARTERIOLAR TGF-?? EXPRESSION WITH PRESERVED RENAL BLOOD FLOW
1999 • 76 citations
MDR1 haplotypes derived from exons 21 and 26 do not affect the steady‐state pharmacokinetics of tacrolimus in renal transplant patients
2004 • 75 citations
Interaction of cyclosporine A and nonsteroidal anti-inflammatory drugs on renal function in patients with rheumatoid arthritis
1992 • 74 citations
Cytochrome P450 3A5 expression in the kidneys of patients with calcineurin inhibitor nephrotoxicity
2007 • 73 citations
Hyponatraemia and hyperkalaemia are more frequent in renal transplant recipients treated with tacrolimus than with cyclosporin. Further evidence for differences between cyclosporin and tacrolimus nephrotoxicities
2004 • 73 citations
Renal and cardiovascular effects of selective cyclooxygenase-2 inhibitors
2001 • 73 citations
Reproducibility of the Banff schema in reporting protocol biopsies of stable renal allografts
2002 • 73 citations
The Evolution of Nonimmune Histological Injury and Its Clinical Relevance in Adult-Sized Kidney Grafts in Pediatric Recipients
2007 • 72 citations
Molecular Comparison of Calcineurin Inhibitor–Induced Fibrogenic Responses in Protocol Renal Transplant Biopsies
2006 • 71 citations
Evolution and Pathophysiology of Renal-Transplant Glomerulosclerosis
2004 • 71 citations
Cyclosporine and the renin-angiotensin axis
1997 • 71 citations
Tissue Distribution of Calcineurin and its Sensitivity to Inhibition by Cyclosporine
2001 • 70 citations
A1adenosine receptor knockout mice are protected against acute radiocontrast nephropathy in vivo
2006 • 70 citations
Interaction of Cyclosporine A and the Renin-Angiotensin System New Perspectives
2002 • 69 citations
Cyclosporine A Suppresses Cyclooxygenase-2 Expression in the Rat Kidney
2002 • 69 citations
Use of Neoral C2 monitoring: a European consensus
2005 • 68 citations
Cyclosporine nephrotoxicity: how does it affect renal allograft function and transplant morphology?
2004 • 68 citations
Relative Tissue Distributions of Cyclosporine and Sirolimus After Concomitant Peroral Administration to the Rat: Evidence for Pharmacokinetic Interactions
1998 • 68 citations
Renal failure after clinical heart transplantation is associated with the TGF-β1 codon 10 gene polymorphism
2000 • 67 citations
Endothelin-1 Induces Cyclooxygenase-2 Expression Via Nuclear Factor of Activated T-Cell Transcription Factor in Glomerular Mesangial Cells
2001 • 67 citations
Cyclosporin exerts a direct fibrogenic effect on human tubulointerstitial cells: roles of insulin-like growth factor I, transforming growth factor beta1, and platelet-derived growth factor.
1999 • 67 citations
Evidence that the inhibition of Na+/K+-ATPase activity by FK506 involves calcineurin
1994 • 66 citations
Distal tubular acidosis induced by FK506
1998 • 66 citations
Apoptosis and adaptive responses to oxidative stress in human endothelial cells exposed to cyclosporin A correlate with BCL‐2 expression levels
2001 • 66 citations
Immunophilin Regulation of Neurotransmitter Release
1996 • 65 citations
Calcineurin inhibitors cause renal afferent activation in rats: a novel mechanism of cyclosporine-induced hypertension
2000 • 65 citations
Cyclosporin A produces distal renal tubular acidosis by blocking peptidyl prolyl cis-trans isomerase activity of cyclophilin
2004 • 65 citations
Focal segmental glomerulosclerosis in renal allografts with chronic nephropathy: Implications for graft survival
1999 • 65 citations
A possible role for nitric oxide in modulating the functional cyclosporine toxicity by arginine
1995 • 63 citations
De novo thrombotic microangiopathy. An underrated complication of renal transplantation
2007 • 63 citations
Differential Effect of Diarrhea on FK506 Versus Cyclosporine A Trough Levels and Resultant Prevention of Allograft Rejection in Renal Transplant Recipients
2002 • 62 citations
Immunosuppressive drug monitoring - what to use in clinical practice today to improve renal graft outcome
2005 • 62 citations
Tacrolimus has less fibrogenic potential than cyclosporin A in a model of renal ischaemia–reperfusion injury
2000 • 62 citations
p-Glycoprotein-mediated transport of a fluorescent rapamycin derivative in renal proximal tubule.
1997 • 61 citations
Predictors of Chronic Kidney Disease in Long-Term Survivors of Lung and Heart-Lung Transplantation
2006 • 61 citations
Muscle function during jumping in frogs. II. Mechanical properties of muscle: implications for system design
1996 • 61 citations
Studies on morphological outcome of cyclosporine-associated arteriolopathy after discontinuation of cyclosporine in renal allografts.
1992 • 61 citations
T cell–directed therapies: lessons learned and future prospects
2006 • 61 citations
Reproducibility Studies on Arteriolar Hyaline Thickening Scoring in Calcineurin Inhibitor-Treated Renal Allograft Recipients
2006 • 60 citations
Low serum magnesium is associated with decreased graft survival in patients with chronic cyclosporin nephrotoxicity
2005 • 59 citations
A Novel, Semiquantitative, Clinically Correlated Calcineurin Inhibitor Toxicity Score for Renal Allograft Biopsies
2006 • 58 citations
Down-regulation of the intrarenal renin-angiotensin system in the aging rat.
1995 • 58 citations
ENHANCEMENT OF FK506 NEPHROTOXICITY BY SODIUM DEPLETION IN AN EXPERIMENTAL RAT MODEL
1994 • 57 citations
Formation of peroxynitrite in vascular endothelial cells exposed to cyclosporine A
2001 • 56 citations
Renocortical mRNA expression of vasoactive factors during spironolactone protective effect in chronic cyclosporine nephrotoxicity
2005 • 56 citations
ROLE OF HYPOMAGNESEMIA IN CHRONIC CYCLOSPORINE NEPHROPATHY1
2002 • 56 citations
Amlodipine, but not MDR1 polymorphisms, alters the pharmacokinetics of cyclosporine A in Japanese kidney transplant recipients1
2003 • 56 citations
Stimulatory effect of cyclosporine A on endothelin secretion by a cultured renal epithelial cell line, LLC-PK1 cells
1990 • 56 citations
Cyclooxygenase-2 Modulates Afferent Arteriolar Responses to Increases in Pressure
1999 • 55 citations
Drug interactions and consequences of sodium restriction
1997 • 55 citations
Conversion From Cyclosporine to Tacrolimus in Patients at Risk for Chronic Renal Allograft Failure: 60-Month Results of the CRAF Study
2008 • 55 citations
Substrate-Dependent Effects of Human ABCB1 Coding Polymorphisms
2008 • 54 citations
Response of human renal tubular cells to cyclosporine and sirolimus: A toxicogenomic study
2008 • 54 citations
The clinical significance of cyclosporine metabolites
1991 • 54 citations
Cyclosporin A stimulates transcription and procollagen secretion in tubulointerstitial fibroblasts and proximal tubular cells.
1990 • 54 citations
Acute Tubular Injury in Protocol Biopsies of Renal Grafts: Prevalence, Associated Factors and Effect on Long-Term Function
2008 • 54 citations
Cyclosporine-induced changes in glomerular filtration rate and urea excretion
1990 • 53 citations
Effect of CsA on the expression of renin and angiotensin type 1 receptor genes in the rat kidney
1993 • 53 citations
Calcineurin Inhibitor–Induced Nephrotoxicity and Renal Expression of P-glycoprotein
2005 • 51 citations
Dietary potassium and magnesium supplementation in cyclosporine-induced hypertension and nephrotoxicity
2000 • 51 citations
Influence of Ciclosporin A on Renal Tubular Function after Kidney Transplantation
1991 • 50 citations
Immunosuppressive activity of cyclosporine metabolites compared and characterized by mass spectroscopy and nuclear magnetic resonance.
1990 • 50 citations
Calcium Modulation of Vascular Smooth Muscle ATP-Sensitive K + Channels
2000 • 50 citations
Tacrolimus-associated hemolytic uremic syndrome: a case analysis.
2003 • 49 citations
EFFECTS OF THE PROSTAGLANDIN E1 ANALOG MISOPROSTOL ON CYCLOSPORINE NEPHROTOXICITY
1988 • 49 citations
Regional haemodynamic effects of cyclosporine A, tacrolimus and sirolimus in conscious rats
2004 • 49 citations
A RANDOMIZED CONTROLLED TRIAL OF VERAPAMIL ON CYCLOSPORINE NEPHROTOXICITY IN HEART AND LUNG TRANSPLANT RECIPIENTS1
1997 • 49 citations
Role of reactive oxygen formation in the cyclosporin-A-mediated impairment of renal functions.
1994 • 48 citations
Impact of the variability of cyclosporin A trough levels on long-term renal allograft function
2002 • 48 citations
Risk factors for long-term renal survival after renal transplantation
1998 • 47 citations
VITAMIN E INHIBITS RENAL mRNA EXPRESSION OF COX II, HO I, TGF??, AND OSTEOPONTIN IN THE RAT MODEL OF CYCLOSPORINE NEPHROTOXICITY
2001 • 47 citations
Cyclosporine A-induced cell cycle arrest and cell death in renal epithelial cells
1999 • 47 citations
Role for TGF-β in Cyclosporine-Induced Modulation of Renal Epithelial Barrier Function
2007 • 45 citations
Relevance of IL10, TGFβ1, TNFα, and IL4Rα Gene Polymorphisms in Kidney Transplantation: A Collaborative Transplant Study Report
2004 • 45 citations
Diverse effects of natural antioxidants on cyclosporin cytotoxicity in rat renal tubular cells
2005 • 45 citations
Role of Intrarenal Endothelin 1, Endothelin 3, and Angiotensin II Expression in Chronic Cyclosporin A Nephrotoxicity in Rats
2000 • 45 citations
Can Donor Implantation Renal Biopsy Predict Long-Term Renal Allograft Outcome?
2007 • 45 citations
Regulation of endothelial NO synthase expression by cyclosporin A in bovine aortic endothelial cells
1996 • 45 citations
Toxicity of Cyclosporine Metabolites
1990 • 44 citations
ANGIOTENSIN GENE POLYMORPHISM AS A DETERMINANT OF POSTTRANSPLANTATION RENAL DYSFUNCTION AND HYPERTENSION1,2
2001 • 44 citations
Ciclosporin metabolite pattern in blood and urine of liver graft recipients
1991 • 44 citations
Different renal toxicity profiles in the association of cyclosporine and tacrolimus with sirolimus in rats
2008 • 43 citations
Proximal Tubular Dysfunction is Associated with Chronic Allograft Nephropathy and Decreased Long-Term Renal-Graft Survival
2004 • 43 citations
Tacrolimus and sirolimus decrease oxidative phosphorylation of isolated rat kidney mitochondria
2003 • 43 citations
Antagonist capacities of nifedipine, captopril, phenoxybenzamine, prostacyclin and indomethacin on cyclosporin A induced impairment of rat renal function
1986 • 43 citations
Follow-up of Kidney Graft Recipients With Cyclosporine-Associated Hemolytic-Uremic Syndrome and Thrombotic Microangiopathy
2005 • 42 citations
Maturation of Dose-Corrected Tacrolimus Predose Trough Levels in Pediatric Kidney Allograft Recipients
2008 • 42 citations
Hyperchloremic metabolic acidosis with high serum potassium in renal transplant recipients: a cyclosporine A associated side effect.
1986 • 41 citations
Ketoconazole-Tacrolimus Coadministration in Kidney Transplant Recipients: Two-Year Results of a Prospective Randomized Study
2006 • 41 citations
Downregulation of Renal Sodium Transporters and Tonicity-Responsive Enhancer Binding Protein by Long-Term Treatment with Cyclosporin A
2007 • 41 citations
Switching from Cyclosporine to Tacrolimus in Patients with Chronic Transplant Dysfunction or Cyclosporine-Induced Adverse Events
2004 • 39 citations
The Impact of Transforming Growth Factor-β1 Gene Polymorphism on End-Stage Renal Failure After Heart Transplantation
2006 • 39 citations
A PROSPECTIVE, RANDOMIZED STUDY OF COADMINISTRATION OF KETOCONAZOLE AND CYCLOSPORINE A IN KIDNEY TRANSPLANT RECIPIENTS: TEN-YEAR FOLLOW-UP
2004 • 39 citations
Chronic cyclosporin A nephrotoxicity, P-glycoprotein overexpression, and relationships with intrarenal angiotensin II deposits.
1997 • 39 citations
Conversion to tacrolimus for the treatment of cyclosporine-associated nephrotoxicity in heart transplant recipients
2002 • 38 citations
PHARMACOKINETICS AND NEPHROTOXICITY OF CYCLOSPORINE IN RENAL TRANSPLANT RECIPIENTS
1985 • 38 citations
CsA LEVELS IN THE EARLY POSTTRANSPLANT PERIOD—PREDICTIVE OF CHRONIC REJECTION IN LIVER TRANSPLANTATION?
1995 • 38 citations
Combined Effects of Losartan and Pravastatin on Interstitial Inflammation and Fibrosis in Chronic Cyclosporine-Induced Nephropathy
2005 • 38 citations
Comparative Acute Nephrotoxicity of FK-506 and Ciclosporin in an Isolated in situ Autoperf used Rat Kidney Model
1997 • 37 citations
Distribution and Activity of Calcineurin in Rat Tissues
1995 • 37 citations
Cyclosporine Concentration Determinations for Monitoring and Pharmacokinetic Studies
1986 • 37 citations
Activation of transcription factors AP-1 and NF-κB in chronic cyclosporine A nephrotoxicity: role in beneficial effects of magnesium supplementation1
2003 • 36 citations
Prevention of Renal Dysfunction and Hypertension by Amlodipine After Heart Transplant
2007 • 36 citations
CORRELATION BETWEEN ANGIOTENSIN-CONVERTING ENZYME GENE INSERTION/DELETION POLYMORPHISM AND KIDNEY GRAFT LONG-TERM OUTCOME IN PEDIATRIC RECIPIENTS
1999 • 36 citations
Effect of 6 weeks of vitamin E administration on renal haemodynamic alterations following a single dose of neoral in healthy volunteers
2001 • 35 citations
Experimental nephrotoxicity, hepatotoxicity and pharmacokinetics of cyclosporin G versus cyclosporin A
1994 • 34 citations
No Association Between Single Nucleotide Polymorphisms and the Development of Nephrotoxicity After Orthotopic Heart Transplantation
2008 • 34 citations
Ciclosporin reduces paracellin-1 expression and magnesium transport in thick ascending limb cells
2007 • 33 citations
Cyclosporine, but not FK506, selectively induces renal and coronary artery smooth muscle contraction
1998 • 33 citations
Clinical validation and reproducibility of the Banff schema for renal allograft pathology.
1995 • 32 citations
POSTTRANSPLANT HEMOLYTIC UREMIC SYNDROME IN ADULT RETRANSPLANTED KIDNEY GRAFT RECIPIENTS: ADVANTAGE OF FK506 THERAPY?
1998 • 32 citations
Cyclosporine A and NAC on the inducible nitric oxide synthase expression and nitric oxide synthesis in rat renal artery cultured cells
2005 • 32 citations
Studies on the effects of cyclosporin A upon renal allograft rejection in the dog.
1980 • 31 citations
Different Effects of Cyclosporine A and FK506 on Potassium Transport Systems in MDCK Cells
2001 • 30 citations
Angiotensin-converting enzyme genotype and renal allograft survival.
1997 • 30 citations
Cyclosporine A attenuates the natriuretic action of loop diuretics by inhibition of renal COX-2 expression
2004 • 30 citations
PGE2 reduces nephrotoxicity and immunosuppression of cyclosporine in rats.
1986 • 30 citations
Role of cytokine gene polymorphisms in acute rejection and renal impairment after liver transplantation
2001 • 30 citations
Cyclosporin A tubular effects contribute to nephrotoxicity: role for Ca2+ and Mg2+ ions
2003 • 30 citations
Long-term protective effect of a calcium antagonist on renal function in hypertensive renal transplant patients on cyclosporine therapy: a 5-year prospective randomized study.
1994 • 29 citations
Factors influencing glomerular filtration rate in renal transplantation after cyclosporine withdrawal using sirolimus‐based therapy: a multivariate analysis of results at five years1
2007 • 29 citations
Sympathetic nerve activity in renal transplant patients before and after withdrawal of cyclosporine
2006 • 28 citations
THE ROLE OF RENAL SYMPATHETIC NERVES IN EXPERIMENTAL CHRONIC CYCLOSPORINE NEPHROPATHY
2000 • 28 citations
Effect of cyclosporine A on Na+/K(+)-ATPase, Na+/K+/2Cl- cotransporter, and H+/K(+)-ATPase in MDCK cells and two subtypes, C7 and C11.
1998 • 27 citations
Loss of renal function following bone marrow transplantation: an analysis of angiotensin converting enzyme D/I polymorphism and other clinical risk factors
2001 • 27 citations
Effects of ACE Inhibition on Cyclosporine A-Induced Hypertension and Nephrotoxicity in Spontaneously Hypertensive Rats on a High-sodium Diet
1999 • 26 citations
Immunohistochemical Analysis of Renin Activity in Chronic Cyclosporine Nephropathy in Childhood Nephrotic Syndrome
2000 • 26 citations
Vascular changes in cyclosporine A-induced hypertension and nephrotoxicity in spontaneously hypertensive rats on high-sodium diet.
2001 • 26 citations
Isolation of an immunosuppressive metabolite of FK506 generated by human microsome preparations
1991 • 25 citations
De novo focal glomerulosclerosis after kidney transplantation
1988 • 25 citations
REVERSIBLE CYCLOSPORINE ARTERIOLOPATHY
1992 • 24 citations
Tacrolimus and Nonsteroidal Anti-Inflammatory Drugs: An Association to Be Avoided
2005 • 24 citations
Indomethacin and cyclosporin together produce marked renal vasoconstriction in humans
1994 • 23 citations
Absorption, Distribution, Metabolism and Excretion of Tacrolimus(FK506) in the Rat.
1998 • 23 citations
Blockade of Angiotensin II with Losartan Attenuates Transforming Growth Factor-β1 Inducible Gene-h3 (βig-h3) Expression in a Model of Chronic Cyclosporine Nephrotoxicity
2005 • 22 citations
Impact of TGFβ1 gene polymorphisms on late renal function in pediatric heart transplantation
2004 • 22 citations
Diclofenac combined with cyclosporine in treatment refractory rheumatoid arthritis: longitudinal safety assessment and evidence of a pharmacokinetic/dynamic interaction.
1996 • 22 citations
L-arginine supplementation in young renal allograft recipients with chronic transplant dysfunction.
2001 • 22 citations
EFFECT OF CYCLOSPORIN A ON NITRIC OXIDE PRODUCTION IN CULTURED LLC-PK1CELLS
2001 • 21 citations
Sublethal heat shock and cyclosporine exposure produce tolerance against subsequent cyclosporine toxicity
1996 • 21 citations
Effect of molsidomine and l-arginine in cyclosporine nephrotoxicity: role of nitric oxide
2004 • 20 citations
Differential interaction of human renal P-glycoprotein with various metabolites and analogues of cyclosporin A
1995 • 20 citations
TIME‐DEPENDENT CYCLOSPORINE A‐INDUCED NEPHROTOXICITY IN RATS
1998 • 19 citations
Case 12-2007
2007 • 19 citations
Overview of FK506 in transplantation.
1990 • 19 citations
Isometric Tubular Epithelial Vacuolization in Renal Allograft Biopsy Specimens of Patients Receiving Low-Dose Intravenous Immunoglobulin for a Positive Crossmatch
2004 • 19 citations
Cyclosporin exposure correlates with 1 year graft function and histological damage in renal transplanted patients
2004 • 19 citations
Cyclosporin A Induces an Atypical Heat Shock Response
2000 • 18 citations
Light microscopic and electron microscopic features of cyclosporine nephrotoxicity in rats
1995 • 18 citations
Cyclosporin-A-induced effects on the free Ca2+ concentration in LLC-PK1-cells and their mechanisms
2000 • 18 citations
Antihypertensive treatment in renal transplant patients--is there a role for ACE inhibitors?
2001 • 17 citations
Distribution of heat shock proteins in kidneys of rats after immunosuppressive treatment with cyclosporine A
2001 • 16 citations
CLINICAL SIGNIFICANCE OF RENAL BIOPSIES SHOWING CONCURRENT ACUTE REJECTION AND TACROLIMUS-ASSOCIATED TUBULAR VACUOLIZATION1
1999 • 16 citations
Angiotensin converting enzyme inhibition and chronic cyclosporine-induced renal dysfunction in type 1 diabetes
1996 • 16 citations
Effects of cyclosporine and its metabolites in the isolated perfused rat kidney.
1993 • 15 citations
High-Dosage Intravenous Immunoglobulin–Associated Macrovacuoles Are Associated with Chronic Tubulointerstitial Lesion Worsening in Renal Transplant Recipients
2008 • 14 citations
Nitric oxide in CsA-induced hypertension: role of β -adrenoceptor antagonist and thromboxane A2
2001 • 13 citations
Association of Cumulative Cyclosporine Dose with Its Irreversible Nephrotoxicity in Japanese Patients with Pediatric-Onset Autoimmune Diseases
2007 • 12 citations
Decreased mineralocorticoid receptor expression in blood cells of kidney transplant recipients undergoing immunosuppressive treatment: cost efficient determination by quantitative PCR
2003 • 12 citations
Cyclosporine nephrotoxicity in rheumatoid arthritis: no effect of short term misoprostol treatment.
1992 • 12 citations
THE EFFECTS OF AGE AND DOSAGE ROUTE ON EXPERIMENTAL CYCLOSPORINE NEPHROTOXICITY
1991 • 12 citations
Juxtaglomerular apparatus of the human kidney: correlation between structure and function.
1982 • 10 citations
Glomerulotubular function in cyclosporine-treated rats. A lithium clearance, occlusion time/transit time and micropuncture study.
1985 • 10 citations
Calcium antagonists in heart transplant recipients: effects on cardiac and renal function and cyclosporine pharmacokinetics.
1993 • 10 citations
Cyclosporine impairs the renal response to volume depletion.
1988 • 9 citations
Studies on morphological outcome of cyclosporine-associated arteriolopathy after discontinuation of cyclosporine in patients with renal allografts.
1993 • 9 citations
Potential Interaction between Prolonged Cyclosporin Administration and Aging in the Rat Kidney
1994 • 9 citations
Inhibition of Purified Human Kidney Na+,K+‐ATPase by Cyclosporine A
2003 • 8 citations
CNI sparing in de novo renal transplantation: 3-year results from the symphony study
2008 • 8 citations
Giant Mitochondria in “Zero-hour” Transplant Biopsies
1992 • 8 citations
MISOPROSTOL PARTIALLY INHIBITS THE RENAL SCARRING OF CHRONIC CYCLOSPORINE NEPHROTOXICITY
1995 • 8 citations
483: Calcineurin-inhibitor associated nephrotoxicity after orthotopic heart transplantation associated with single nucleotide polymorphisms (SNP)
2007 • 3 citations
42 Follow-up of Kidney Graft Recipients with Cyclosporine Associated Hemolytic Uremic Syndrome and Thrombotic Microangiopathy
2005 • 2 citations
VOCLOSPORIN (ISA 247): THE PHASE 2 'PROMISE' DE NOVO RENAL TRANSPLANT TRIAL DEMONSTRATES EFFICACY AND AN IMPROVED SAFETY PROFILE ACROSS A WIDE THERAPEUTIC RANGE
2008 • 1 citations